Search Results - "Padi, Sathish K R"
-
1
The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer
Published in Nature communications (21-12-2021)“…Neuroendocrine (NE) prostate cancer (NEPC) is a lethal subtype of castration-resistant prostate cancer (PCa) arising either de novo or from transdifferentiated…”
Get full text
Journal Article -
2
MMP‑9 Responsive PEG Cleavable Nanovesicles for Efficient Delivery of Chemotherapeutics to Pancreatic Cancer
Published in Molecular pharmaceutics (07-07-2014)“…Significant differences in biochemical parameters between normal and tumor tissues offer an opportunity to chemically design drug carriers which respond to…”
Get full text
Journal Article -
3
PIM protein kinases regulate the level of the long noncoding RNA H19 to control stem cell gene transcription and modulate tumor growth
Published in Molecular oncology (01-05-2020)“…The proviral integration site for Moloney murine leukemia virus (PIM) serine/threonine kinases have an oncogenic and prosurvival role in hematological and…”
Get full text
Journal Article -
4
EDC3 phosphorylation regulates growth and invasion through controlling P-body formation and dynamics
Published in EMBO reports (07-04-2021)“…Regulation of mRNA stability and translation plays a critical role in determining protein abundance within cells. Processing bodies (P-bodies) are critical…”
Get full text
Journal Article -
5
“Root”ing for successful T-ALL treatment
Published in Blood (06-05-2021)“…In this issue of Blood , Anand et al 1 provide compelling evidence that resistance to Notch inhibitor therapy in early T-cell precursor acute lymphoblastic…”
Get full text
Journal Article -
6
Cryo-EM structures of PP2A:B55–FAM122A and PP2A:B55–ARPP19
Published in Nature (London) (04-01-2024)“…Progression through the cell cycle is controlled by regulated and abrupt changes in phosphorylation 1 . Mitotic entry is initiated by increased phosphorylation…”
Get full text
Journal Article -
7
MicroRNA-627 Mediates the Epigenetic Mechanisms of Vitamin D to Suppress Proliferation of Human Colorectal Cancer Cells and Growth of Xenograft Tumors in Mice
Published in Gastroenterology (New York, N.Y. 1943) (01-08-2013)“…Background & Aims Vitamin D protects against colorectal cancer through unclear mechanisms. We investigated the effects of calcitriol (1α,25-dihydroxyvitamin D3…”
Get full text
Journal Article -
8
Phosphorylation of DEPDC5, a component of the GATOR1 complex, releases inhibition of mTORC1 and promotes tumor growth
Published in Proceedings of the National Academy of Sciences - PNAS (08-10-2019)“…The Pim and AKT serine/threonine protein kinases are implicated as drivers of cancer. Their regulation of tumor growth is closely tied to the ability of these…”
Get full text
Journal Article -
9
PIM Kinase Inhibitors Block the Growth of Primary T-cell Acute Lymphoblastic Leukemia: Resistance Pathways Identified by Network Modeling Analysis
Published in Molecular cancer therapeutics (01-09-2020)“…Despite significant progress in understanding the genetic landscape of T-cell acute lymphoblastic leukemia (T-ALL), the discovery of novel therapeutic targets…”
Get full text
Journal Article -
10
Targeting the PIM protein kinases for the treatment of a T-cell acute lymphoblastic leukemia subset
Published in Oncotarget (02-05-2017)“…New approaches are needed for the treatment of patients with T-cell acute lymphoblastic leukemia (T-ALL) who fail to achieve remission with chemotherapy…”
Get full text
Journal Article -
11
Insulin receptor substrate 1 is a substrate of the Pim protein kinases
Published in Oncotarget (12-04-2016)“…The Pim family of serine/threonine protein kinases (Pim 1, 2, and 3) contribute to cellular transformation by regulating glucose metabolism, protein synthesis,…”
Get full text
Journal Article -
12
High-resolution structures of two phosphatase-inhibitor complexes
Published in Nature (London) (20-12-2023)Get full text
Journal Article -
13
Mechanisms Behind Resistance to PI3K Inhibitor Treatment Induced by the PIM Kinase
Published in Molecular cancer therapeutics (01-12-2018)“…Cancer resistance to PI3K inhibitor therapy can be in part mediated by increases in the PIM1 kinase. However, the exact mechanism by which PIM kinase promotes…”
Get full text
Journal Article